COVINGTON, Ky. — CTI Clinical Trial and Consulting Services, a multi-national, privately-held, full-service contract research organization was honored by Cincinnati Business Courier at the 2019 Innovation & Technology awards.
CTI was named a finalist in the Outstanding Bioscience Innovation award category. This award recognizes a company that has achieved a significant milestone in the life sciences.
“We’re honored to be chosen by the Cincinnati Business Courier as a finalist for this award recognizing our team’s innovative work,” said Timothy J. Schroeder, founder and CEO. “It is an exciting time in the drug development industry in which we are able to work on programs that don’t just treat diseases, but may ultimately cure them. Our success is a testament to the dedication of our employees, and we look forward to seeing what further medical advances come from their hard work.”
The annual awards program highlights successes in the technology industry and innovation in the Cincinnati/Northern Kentucky region.
CTI was founded in Cincinnati in 1999, and has quickly grown from a team of less than 10 in a renovated carriage house to a global company of more than 700 associates working from offices around the world.
This recognition as one of the region’s leaders follows a long history of local and industry acknowledgements, recently including recognition from the Northern Kentucky Chamber of Commerce at the Business Impact awards and receipt of the Prix Galien – Medstartup Award in the category “Best Innovative Trial Design Leading to Quicker and Better Therapeutic Outcome,” given by the Galien Foundation and Business France.